High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane
Biotechnology Journal · 2024
DOI: 10.1002/biot.202400098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Jia Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Science Center for Future Foods, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Recombinant Proteins, Protein Engineering, Carboxypeptidase B, Cell Membrane. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Environmental Protection Bureau.
Abstract (Originalsprache)
Human carboxypeptidase B1 (hCPB1) is vital for recombinant insulin production, holding substantial value in the pharmaceutical industry. Current challenges include limited hCPB1 enzyme activity. In this study, recombinant hCPB1 efficient expression in Pichia pastoris was achieved. To enhance hCPB1 secretion, we conducted signal peptides screening and deleted the Vps10 sortilin domain, reducing vacuolar mis‐sorting. Overexpression of Sec4p increased the fusion of secretory vesicles with the plasma membrane and improved hCPB1 secretion by 20%. Rational protein engineering generated twenty‐two single‐mutation mutants and identified the A178L mutation resulted in a 30% increase in hCPB1 specific activity. However, all combinational mutations that increased specific activities decreased protein expression levels. Therefore, computer‐aided global protein design with PROSS was employed for the aim of improving specific activities and preserving good protein expression. Among the six designed mutants, hCPB1‐P6 showed a remarkable 114% increase in the catalytic rate constant ( k cat ), a 137% decrease in the Michaelis constant ( K m ), and a 490% increase in catalytic efficiency. Most mutations occurred on the surface of hCPB1‐P6, with eight sites mutated to proline. In a 5 L fermenter, hCPB1‐P6 was produced by the secretion‐enhanced P. pastoris chassis to 199.6 ± 20 mg L −1 with a specific activity of 96 ± 0.32 U mg −1 , resulting in a total enzyme activity of 19137 ± 1131 U L −1 , demonstrating significant potential for industrial applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Science Center for Future Foods, Jiangnan University, Wuxi, China.
- The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China.
- The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China.
Förderung
- National Natural Science Foundation of China
- Chongqing Municipal Environmental Protection Bureau
Zitieren
APA
Li, J., Shao, Q., Xiang, Y., Li, J., Chen, J., Du, G., Kang, Z., & Wang, Y. (2024). High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane. Biotechnology Journal. https://doi.org/10.1002/biot.202400098
Vancouver
Li J, Shao Q, Xiang Y, Li J, Chen J, Du G, et al. High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane. Biotechnology Journal. 2024. doi:10.1002/biot.202400098
BibTeX
@article{Li2024,
author = {Li, Jia and Shao, Qinan and Xiang, Yulong and Li, Jianghua and Chen, Jian and Du, Guocheng and Kang, Zhen and Wang, Yang},
title = {High‐activity recombinant human carboxypeptidase B expression in Pichia pastoris through rational protein engineering and enhancing secretion from the Golgi apparatus to the plasma membrane},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202400098}
}
EUVIMED